BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30661467)

  • 1. Differentially expressed plasma proteins of β-thalassemia/hemoglobin E patients in response to curcuminoids/vitamin E antioxidant cocktails.
    Panachan J; Chokchaichamnankit D; Weeraphan C; Srisomsap C; Masaratana P; Hatairaktham S; Panichkul N; Svasti J; Kalpravidh RW
    Hematology; 2019 Dec; 24(1):300-307. PubMed ID: 30661467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of curcuminoids in ameliorating oxidative modification in β-thalassemia/Hb E plasma proteome.
    Weeraphan C; Srisomsap C; Chokchaichamnankit D; Subhasitanont P; Hatairaktham S; Charoensakdi R; Panichkul N; Siritanaratkul N; Fucharoen S; Svasti J; Kalpravidh RW
    J Nutr Biochem; 2013 Mar; 24(3):578-85. PubMed ID: 22818714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of β-Thalassemia/Hemoglobin E with Antioxidant Cocktails Results in Decreased Oxidative Stress, Increased Hemoglobin Concentration, and Improvement of the Hypercoagulable State.
    Yanpanitch OU; Hatairaktham S; Charoensakdi R; Panichkul N; Fucharoen S; Srichairatanakool S; Siritanaratkul N; Kalpravidh RW
    Oxid Med Cell Longev; 2015; 2015():537954. PubMed ID: 26078808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential plasma proteome profiles of mild versus severe β-thalassemia/Hb E.
    Hatairaktham S; Srisawat C; Siritanaratkul N; Chiangjong W; Fucharoen S; Thongboonkerd V; Kalpravidh RW
    Ann Hematol; 2013 Mar; 92(3):365-77. PubMed ID: 23161390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent β-thalassemia/Hb E patients.
    Hatairaktham S; Masaratana P; Hantaweepant C; Srisawat C; Sirivatanauksorn V; Siritanaratkul N; Panichkul N; Kalpravidh RW
    Ann Hematol; 2021 Apr; 100(4):891-901. PubMed ID: 33388858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids.
    Kalpravidh RW; Siritanaratkul N; Insain P; Charoensakdi R; Panichkul N; Hatairaktham S; Srichairatanakool S; Phisalaphong C; Rachmilewitz E; Fucharoen S
    Clin Biochem; 2010 Mar; 43(4-5):424-9. PubMed ID: 19900435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron chelation therapy with deferiprone improves oxidative status and red blood cell quality and reduces redox-active iron in β-thalassemia/hemoglobin E patients.
    Morales NP; Rodrat S; Piromkraipak P; Yamanont P; Paiboonsukwong K; Fucharoen S
    Biomed Pharmacother; 2022 Jan; 145():112381. PubMed ID: 34736078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Acetylcysteine supplementation reduces oxidative stress and DNA damage in children with β-thalassemia.
    Ozdemir ZC; Koc A; Aycicek A; Kocyigit A
    Hemoglobin; 2014; 38(5):359-64. PubMed ID: 25222041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent β-thalassemia.
    Haghpanah S; Cohan N; Bordbar M; Bazrafshan A; Karimi M; Zareifar S; Safaei S; Aramesh A; Moghadam M; Fard SAZ; Zekavat OR
    Ann Hematol; 2021 Mar; 100(3):635-644. PubMed ID: 33216196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E.
    Das N; Das Chowdhury T; Chattopadhyay A; Datta AG
    Pol J Pharmacol; 2004; 56(1):85-96. PubMed ID: 15047982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefits of vitamin C and vitamin E in children with beta-thalassemia with high oxidative stress.
    Dissayabutra T; Tosukhowong P; Seksan P
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S317-21. PubMed ID: 16623048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of protein profiling studies of β-thalassemia/Hb E disease.
    Lithanatudom P; Smith DR
    Proteomics Clin Appl; 2016 Nov; 10(11):1093-1102. PubMed ID: 27511747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of redox proteins and chaperones in HbEβ-thalassemia erythrocyte proteome.
    Bhattacharya D; Saha S; Basu S; Chakravarty S; Chakravarty A; Banerjee D; Chakrabarti A
    Proteomics Clin Appl; 2010 May; 4(5):480-8. PubMed ID: 21137065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizations and proteome analysis of platelet-free plasma-derived microparticles in β-thalassemia/hemoglobin E patients.
    Chaichompoo P; Kumya P; Khowawisetsut L; Chiangjong W; Chaiyarit S; Pongsakul N; Sirithanaratanakul N; Fucharoen S; Thongboonkerd V; Pattanapanyasat K
    J Proteomics; 2012 Dec; 76 Spec No.():239-50. PubMed ID: 22705320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants?
    Rachmilewitz EA; Weizer-Stern O; Adamsky K; Amariglio N; Rechavi G; Breda L; Rivella S; Cabantchik ZI
    Ann N Y Acad Sci; 2005; 1054():118-23. PubMed ID: 16339657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Paraoxonase Activity and Malondialdehyde Serum Concentrations Remain Unaffected in Response to Hydroxyurea Therapy in β-Thalassemia Patients.
    Zohaib M; Ansari SH; Hashim Z; Shamsi TS; Zarina S
    J Clin Pharmacol; 2016 Jul; 56(7):869-74. PubMed ID: 26608512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of Curcumin Supplementation on Antioxidant Status in β-Thalassemia Major Patients: A Double-Blind Randomized Controlled Clinical Trial.
    Nasseri E; Mohammadi E; Tamaddoni A; Qujeq D; Zayeri F; Zand H
    Ann Nutr Metab; 2017; 71(3-4):136-144. PubMed ID: 28881347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study.
    Sutipornpalangkul W; Morales NP; Unchern S; Sanvarinda Y; Chantharaksri U; Fucharoen S
    J Med Assoc Thai; 2012 Jan; 95(1):29-36. PubMed ID: 22379738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for the introduction of targeted antioxidant drugs for the prevention and treatment of diseases related to free radical pathology.
    Kontoghiorghes GJ; Kontoghiorghe CN
    Expert Opin Investig Drugs; 2019 Jul; 28(7):593-603. PubMed ID: 31185180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant status in beta thalassemia major: a single-center study.
    Waseem F; Khemomal KA; Sajid R
    Indian J Pathol Microbiol; 2011; 54(4):761-3. PubMed ID: 22234105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.